RSV Burden in Outpatient Settings (Oursyn)

  • STATUS
    Recruiting
  • End date
    Jan 11, 2024
  • participants needed
    2900
  • sponsor
    Association Clinique Thérapeutique Infantile du val de Marne
Updated on 4 October 2022
pneumonia
fever
dysphagia
chest x-ray
dyspnea
congestion
x-rays
otorrhea
influenza
cough
nasal congestion
rhinorrhea
shortness of breath
diagnostic procedures
respiratory tract infection
acute suppurative otitis media

Summary

Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)

Description

The study protocol is designed with three key components: 1. Build on existing PARI outpatient syndromic surveillance by adding laboratory multiplex testing of LRTI samples (RSV, Influenza, SARS-COV-2) 2. Follow all bronchiolitis through the PARI RWE database and document "patient journey" for 5 years after first medical visit 3. Review the electronic PARI data of three previous seasons in order to document the impact of LRTI attributable to RSV in children < 2 years in France prior to enhanced surveillance

Details
Condition RSV Infection, Children, Only, Outpatient, Bronchiolitis, Otitis Media, Pneumonia
Treatment nasopharyngeal samples
Clinical Study IdentifierNCT04743609
SponsorAssociation Clinique Thérapeutique Infantile du val de Marne
Last Modified on4 October 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

children under 24 months of age (≤)
One of the holders of parental authority signed the consent
Patient affiliated to a social security scheme (Social Security or Universal Medical Coverage)
First episode of bronchiolitis defined by
Age ≤24 months
At least one symptom from group A and one symptom from group B Group A (one or more)
Fever >38 °C
Cough
Otalgia
Nasal congestion
Rhinorrhea
Coryza
Dysphagia Group B (one or more)
whistling
Crackles
Rales
Decrease in respiratory noise
Shortness of breath
Dyspnea
OR Acute purulent otitis media (Paradise Criteria) or otorrhea
OR Pneumonia defined by the presence of opacity of parenchymal condensation and/or pleural effusion on chest X-ray associated with fever

Exclusion Criteria

Age >24 months
Refusal by one of the parents
Not affiliated to a social security system
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note